These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 31533487)
1. Liquid biopsies in pancreatic cancer. Kamyabi N; Bernard V; Maitra A Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487 [No Abstract] [Full Text] [Related]
2. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA. Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883 [TBL] [Abstract][Full Text] [Related]
3. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project. Bardol T; Dujon AM; Taly V; Dunyach-Remy C; Lavigne JP; Costa-Silva B; Kurma K; Eslami-S Z; Cayrefourcq L; Canivet C; Muscari F; Bournet B; Alix-Panabières C BMC Cancer; 2024 Jun; 24(1):709. PubMed ID: 38853244 [TBL] [Abstract][Full Text] [Related]
4. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505 [TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. Stosic K; Senar OA; Tarfouss J; Bouchart C; Navez J; Van Laethem JL; Arsenijevic T Cells; 2023 Dec; 13(1):. PubMed ID: 38201207 [TBL] [Abstract][Full Text] [Related]
6. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review. Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919 [TBL] [Abstract][Full Text] [Related]
7. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis. Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514 [TBL] [Abstract][Full Text] [Related]
8. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer. Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794 [TBL] [Abstract][Full Text] [Related]
9. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma? Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604 [No Abstract] [Full Text] [Related]
10. The Different Facets of Liquid Biopsy: A Kaleidoscopic View. Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226 [TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer. Watanabe F; Suzuki K; Noda H; Rikiyama T World J Gastroenterol; 2022 Dec; 28(46):6478-6496. PubMed ID: 36569270 [TBL] [Abstract][Full Text] [Related]
15. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA. Takahashi K; Inuzuka T; Shimizu Y; Sawamoto K; Taniue K; Ono Y; Asai F; Koyama K; Sato H; Kawabata H; Iwamoto H; Yamakita K; Kitano Y; Teramoto T; Fujiya M; Fujii S; Mizukami Y; Okumura T Pancreas; 2024 May; 53(5):e395-e404. PubMed ID: 38416857 [TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application. Sivapalan L; Kocher HM; Ross-Adams H; Chelala C Pancreatology; 2021 Mar; 21(2):363-378. PubMed ID: 33451936 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592 [TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer. Hagey DW; Kordes M; Görgens A; Mowoe MO; Nordin JZ; Moro CF; Löhr JM; El Andaloussi S J Extracell Vesicles; 2021 Oct; 10(12):e12142. PubMed ID: 34595842 [TBL] [Abstract][Full Text] [Related]
19. Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis. Yin L; Pu N; Thompson E; Miao Y; Wolfgang C; Yu J Clin Cancer Res; 2021 Feb; 27(3):740-748. PubMed ID: 33082211 [TBL] [Abstract][Full Text] [Related]
20. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer. Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]